ScienceDex / Researcher record
Nordstrom, Jeffrey
- Macrogenics, Inc. (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $7,449,454 | 1 | #340 |
| 2017 | $10,790,360 | 1 | #120 |
| 2018 | $1,263,565 | 1 | #5,532 |
| 2021 | $6,287,950 | 1 | #499 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20151 record
- FY20171 record
- FY20181 record
- FY2021 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Nordstrom, Jeffrey as a PI. Multi-PI records show the full award amount for context.
- 272201500032C-P00008-9999-1N01Contact PIDUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION$6.3Maward amount
Award organization
Organizations that administered FY2021 awards listing Nordstrom, Jeffrey as a PI.
FY2021 award administered by Macrogenics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardMacrogenics, Inc.
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015$5M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #340
- 2015Entered Top 25% NationallyRanked #340
- 2015Entered Top 10% NationallyRanked #340
- 2015Entered Top 5% NationallyRanked #340
- 2017$10M Cumulative Funding
- 2017Entered Top 1% NationallyRanked #120
- 2021$25M Cumulative Funding